Promis Neurosciences Stock Technical Analysis
| PMN Stock | USD 14.05 0.11 0.78% |
As of the 3rd of February, ProMIS Neurosciences holds the Risk Adjusted Performance of 0.0736, coefficient of variation of 1132.86, and Semi Deviation of 5.35. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of ProMIS Neurosciences, as well as the relationship between them.
ProMIS Neurosciences Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as ProMIS, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ProMISProMIS Neurosciences' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.ProMIS Neurosciences Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 106.35 | Strong Buy | 3 | Odds |
Most ProMIS analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand ProMIS stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of ProMIS Neurosciences, talking to its executives and customers, or listening to ProMIS conference calls.
Will Biotechnology sector continue expanding? Could ProMIS diversify its offerings? Factors like these will boost the valuation of ProMIS Neurosciences. Anticipated expansion of ProMIS directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every ProMIS Neurosciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
ProMIS Neurosciences's market price often diverges from its book value, the accounting figure shown on ProMIS's balance sheet. Smart investors calculate ProMIS Neurosciences' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since ProMIS Neurosciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between ProMIS Neurosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding ProMIS Neurosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, ProMIS Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ProMIS Neurosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ProMIS Neurosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ProMIS Neurosciences.
| 11/05/2025 |
| 02/03/2026 |
If you would invest 0.00 in ProMIS Neurosciences on November 5, 2025 and sell it all today you would earn a total of 0.00 from holding ProMIS Neurosciences or generate 0.0% return on investment in ProMIS Neurosciences over 90 days. ProMIS Neurosciences is related to or competes with MapLight Therapeutics, Eterna Therapeutics, OSR Holdings, Lipocine, Edesa Biotech, Adlai Nortye, and GeoVax Labs. ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative di... More
ProMIS Neurosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ProMIS Neurosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ProMIS Neurosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 6.32 | |||
| Information Ratio | 0.0799 | |||
| Maximum Drawdown | 38.1 | |||
| Value At Risk | (7.69) | |||
| Potential Upside | 13.32 |
ProMIS Neurosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ProMIS Neurosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ProMIS Neurosciences' standard deviation. In reality, there are many statistical measures that can use ProMIS Neurosciences historical prices to predict the future ProMIS Neurosciences' volatility.| Risk Adjusted Performance | 0.0736 | |||
| Jensen Alpha | 0.5504 | |||
| Total Risk Alpha | 0.1618 | |||
| Sortino Ratio | 0.0839 | |||
| Treynor Ratio | 1.01 |
ProMIS Neurosciences February 3, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0736 | |||
| Market Risk Adjusted Performance | 1.02 | |||
| Mean Deviation | 4.62 | |||
| Semi Deviation | 5.35 | |||
| Downside Deviation | 6.32 | |||
| Coefficient Of Variation | 1132.86 | |||
| Standard Deviation | 6.64 | |||
| Variance | 44.15 | |||
| Information Ratio | 0.0799 | |||
| Jensen Alpha | 0.5504 | |||
| Total Risk Alpha | 0.1618 | |||
| Sortino Ratio | 0.0839 | |||
| Treynor Ratio | 1.01 | |||
| Maximum Drawdown | 38.1 | |||
| Value At Risk | (7.69) | |||
| Potential Upside | 13.32 | |||
| Downside Variance | 39.98 | |||
| Semi Variance | 28.58 | |||
| Expected Short fall | (5.64) | |||
| Skewness | 0.3502 | |||
| Kurtosis | 2.22 |
ProMIS Neurosciences Backtested Returns
ProMIS Neurosciences appears to be not too volatile, given 3 months investment horizon. ProMIS Neurosciences maintains Sharpe Ratio (i.e., Efficiency) of 0.11, which implies the firm had a 0.11 % return per unit of risk over the last 3 months. By analyzing ProMIS Neurosciences' technical indicators, you can evaluate if the expected return of 0.75% is justified by implied risk. Please evaluate ProMIS Neurosciences' Semi Deviation of 5.35, risk adjusted performance of 0.0736, and Coefficient Of Variation of 1132.86 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, ProMIS Neurosciences holds a performance score of 8. The company holds a Beta of 0.57, which implies possible diversification benefits within a given portfolio. As returns on the market increase, ProMIS Neurosciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding ProMIS Neurosciences is expected to be smaller as well. Please check ProMIS Neurosciences' value at risk, as well as the relationship between the skewness and price action indicator , to make a quick decision on whether ProMIS Neurosciences' historical price patterns will revert.
Auto-correlation | -0.05 |
Very weak reverse predictability
ProMIS Neurosciences has very weak reverse predictability. Overlapping area represents the amount of predictability between ProMIS Neurosciences time series from 5th of November 2025 to 20th of December 2025 and 20th of December 2025 to 3rd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ProMIS Neurosciences price movement. The serial correlation of -0.05 indicates that only as little as 5.0% of current ProMIS Neurosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.05 | |
| Spearman Rank Test | -0.47 | |
| Residual Average | 0.0 | |
| Price Variance | 4.43 |
ProMIS Neurosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
ProMIS Neurosciences Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Normalized Average True Range is used to analyze tradable apportunities for ProMIS Neurosciences across different markets.
About ProMIS Neurosciences Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of ProMIS Neurosciences on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of ProMIS Neurosciences based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on ProMIS Neurosciences price pattern first instead of the macroeconomic environment surrounding ProMIS Neurosciences. By analyzing ProMIS Neurosciences's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of ProMIS Neurosciences's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to ProMIS Neurosciences specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Net Current Asset Value | 583.44 | 518.62 | Days Payables Outstanding | 246.67 | 259.0 |
ProMIS Neurosciences February 3, 2026 Technical Indicators
Most technical analysis of ProMIS help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ProMIS from various momentum indicators to cycle indicators. When you analyze ProMIS charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0736 | |||
| Market Risk Adjusted Performance | 1.02 | |||
| Mean Deviation | 4.62 | |||
| Semi Deviation | 5.35 | |||
| Downside Deviation | 6.32 | |||
| Coefficient Of Variation | 1132.86 | |||
| Standard Deviation | 6.64 | |||
| Variance | 44.15 | |||
| Information Ratio | 0.0799 | |||
| Jensen Alpha | 0.5504 | |||
| Total Risk Alpha | 0.1618 | |||
| Sortino Ratio | 0.0839 | |||
| Treynor Ratio | 1.01 | |||
| Maximum Drawdown | 38.1 | |||
| Value At Risk | (7.69) | |||
| Potential Upside | 13.32 | |||
| Downside Variance | 39.98 | |||
| Semi Variance | 28.58 | |||
| Expected Short fall | (5.64) | |||
| Skewness | 0.3502 | |||
| Kurtosis | 2.22 |
ProMIS Neurosciences February 3, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as ProMIS stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | (Huge) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 14.05 | ||
| Day Typical Price | 14.05 | ||
| Price Action Indicator | (0.05) |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProMIS Neurosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in ProMIS Stock, please use our How to Invest in ProMIS Neurosciences guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Will Biotechnology sector continue expanding? Could ProMIS diversify its offerings? Factors like these will boost the valuation of ProMIS Neurosciences. Anticipated expansion of ProMIS directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every ProMIS Neurosciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
ProMIS Neurosciences's market price often diverges from its book value, the accounting figure shown on ProMIS's balance sheet. Smart investors calculate ProMIS Neurosciences' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since ProMIS Neurosciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between ProMIS Neurosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding ProMIS Neurosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, ProMIS Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.